CABG and PCI Comparable in ACS Patients With Left Main CAD
The results line up with an all-comers analysis and point to an evolving understanding of how to treat LM CAD, say experts.
Source: tctmd.com
Stay updated with breaking news from Brian Bergmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The results line up with an all-comers analysis and point to an evolving understanding of how to treat LM CAD, say experts.
The findings provide insight into the relationship between cardiovascular biomarkers, coronary anatomical complexity, and incident clinical events.
Researchers hold little hope for this compound, which had a poor safety profile, but suggest the ANGPTL3 story isn’t over.
An investigational antisense oligonucleotide drug targeting a novel cholesterol pathway showed disappointing results in this phase 2b study.